10-125823570-T-C
Variant summary
Our verdict is Likely benign. Variant got -4 ACMG points: 2P and 6B. PM2BP4_StrongBP6_Moderate
The NM_078468.3(BCCIP):c.13T>C(p.Ser5Pro) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000039 in 1,613,524 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (★).
Frequency
Consequence
NM_078468.3 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -4 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
BCCIP | NM_078468.3 | c.13T>C | p.Ser5Pro | missense_variant | 1/7 | ENST00000278100.11 | |
BCCIP | NM_016567.4 | c.13T>C | p.Ser5Pro | missense_variant | 1/8 | ||
BCCIP | NM_078469.3 | c.13T>C | p.Ser5Pro | missense_variant | 1/7 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
BCCIP | ENST00000278100.11 | c.13T>C | p.Ser5Pro | missense_variant | 1/7 | 1 | NM_078468.3 | P1 | |
BCCIP | ENST00000368759.5 | c.13T>C | p.Ser5Pro | missense_variant | 1/8 | 1 | |||
BCCIP | ENST00000299130.7 | c.13T>C | p.Ser5Pro | missense_variant | 1/7 | 1 | |||
BCCIP | ENST00000463330.5 | upstream_gene_variant | 3 |
Frequencies
GnomAD3 genomes ? AF: 0.0000132 AC: 2AN: 151990Hom.: 0 Cov.: 33
GnomAD3 exomes AF: 0.0000161 AC: 4AN: 248702Hom.: 0 AF XY: 0.00000743 AC XY: 1AN XY: 134630
GnomAD4 exome AF: 0.0000417 AC: 61AN: 1461534Hom.: 0 Cov.: 31 AF XY: 0.0000454 AC XY: 33AN XY: 727094
GnomAD4 genome ? AF: 0.0000132 AC: 2AN: 151990Hom.: 0 Cov.: 33 AF XY: 0.0000135 AC XY: 1AN XY: 74224
ClinVar
Submissions by phenotype
not specified Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Ambry Genetics | May 11, 2022 | This alteration is classified as likely benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at